These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 35812383)

  • 1. Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.
    Hu Z; Lu SH; Lowrie DB; Fan XY
    Front Immunol; 2022; 13():895020. PubMed ID: 35812383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice.
    Kirk NM; Huang Q; Vrba S; Rahman M; Block AM; Murphy H; White DW; Namugenyi SB; Ly H; Tischler AD; Liang Y
    Front Immunol; 2023; 14():1127515. PubMed ID: 36845108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled aerosol viral-vectored vaccines against tuberculosis.
    Stylianou E; Satti I
    Curr Opin Virol; 2024 Jun; 66():101408. PubMed ID: 38574628
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans.
    Jeyanathan M; Fritz DK; Afkhami S; Aguirre E; Howie KJ; Zganiacz A; Dvorkin-Gheva A; Thompson MR; Silver RF; Cusack RP; Lichty BD; O'Byrne PM; Kolb M; Medina MFC; Dolovich MB; Satia I; Gauvreau GM; Xing Z; Smaill F
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Latest advances in the development of tuberculosis vaccines in global clinical trials: a review].
    Zhou F; Zhang Y; Zhang D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):201-206. PubMed ID: 38857967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.
    Jeyanathan M; Thanthrige-Don N; Afkhami S; Lai R; Damjanovic D; Zganiacz A; Feng X; Yao XD; Rosenthal KL; Medina MF; Gauldie J; Ertl HC; Xing Z
    Mucosal Immunol; 2015 Nov; 8(6):1373-87. PubMed ID: 25872483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.
    Zhou F; Zhang D
    Front Immunol; 2023; 14():1238649. PubMed ID: 38022657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in protein subunit vaccines against tuberculosis.
    Zhang Y; Xu JC; Hu ZD; Fan XY
    Front Immunol; 2023; 14():1238586. PubMed ID: 37654500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis.
    Scriba TJ; Netea MG; Ginsberg AM
    Semin Immunol; 2020 Aug; 50():101431. PubMed ID: 33279383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine development against tuberculosis before and after Covid-19.
    Kaufmann SHE
    Front Immunol; 2023; 14():1273938. PubMed ID: 38035095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal bovine β-defensin-5 enhances antituberculosis immunity in a mouse model by a novel protein-based respiratory mucosal vaccine.
    Liang Z; Li H; Qu M; Liu Y; Wang Y; Wang H; Dong Y; Chen Y; Ge X; Zhou X
    Virulence; 2022 Dec; 13(1):949-962. PubMed ID: 35603910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.
    Kim H; Choi HG; Shin SJ
    Front Immunol; 2023; 14():1193058. PubMed ID: 37638056
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.